Patent ID: 8846036
Filing Date: 2014-09-30
Classification: C07K

Abstract:
1. An isolated antibody comprising a complementary determining region (CDR) heavy chain 1, a CDR heavy chain 2, a CDR heavy chain 3, a CDR light chain 1, a CDR light chain 2, and a CDR light chain 3, wherein the CDR heavy chain 1 comprises an amino acid sequence of SEQ ID NO:8, the CDR heavy chain 2 comprises an amino acid sequence of SEQ ID NO:9, the CDR heavy chain 3 comprises an amino acid sequence of SEQ ID NO:10, the CDR light chain 1 comprises an amino acid sequence of SEQ ID NO:12, the CDR light chain 2 comprises an amino acid sequence of SEQ ID NO:13 and the CDR light chain 3 comprises an amino acid sequence of SEQ ID NO:14, wherein the antibody specifically binds to human NGAL protein.